SRD5A1 and ovarian cancer: Similarly, TWP’s suppression of SRD5A1 may attenuate androgen signaling, which contributes to progression in a significant subset of ovarian cancers, offering a novel strategy to counteract hormone-mediated chemoresistance (Mizushima and Miyamoto, 2019; Chung et al., 2021).